Insurance type has been reported to be an independent predictor of overall survival in lung cancer patients. These investigators found differences in odds of 5-year survival and disposition at discharge between patients with public and combination insurance plans and those with private insurance, supporting their hypothesis that patients who do not have a fully private insurance plan have less favorable outcomes after their surgical treatment.
